DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
A flow cytometry-based method to screen for modulators of tumor-specific T cell cytotoxicity
Cancer immunotherapy relies on the ability of immune cells to kill malignant cells. The cytotoxic T lymphocyte (CTL) response is perhaps the functional measure that best reflects cell-mediated immunity against cancer. Straightforward methods that facilitate quantitative evaluation of the potency of compounds that can modulate T cell-mediated, tumor antigen-specific immune responses are central in the screening cascade when searching for new immunotherapeutic agents for cancer. Here we describe a simple, sensitive method, based on flow cytometry analyses, to quantitatively measure cytotoxicity in vitro. We provide examples that validate its feasibility and specificity using CD8+ T lymphocytes specific for a surrogate tumor antigen, and a blocking antibody for the inhibitory PD-1/PD-L1 axis. This method can nonetheless be applied to the screening of virtually any cytotoxicity modulatory compound, including antibodies and small molecules or T cell-based therapies, and can be scaled up for high-throughput workflow and automation., This work was funded by grants from the Spanish Ministerio de Economía y Competitividad (MINECO) (SAF2017-83732-R; AEI/FEDER, EU), the Comunidad de Madrid (B2017/BMD-3733; Immunothercan-CM), and the Merck-Salud Foundation. J.S. is supported by a predoctoral fellowship from the MINECO and the EU European Social Fund., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2017-83732-R
DOI: http://hdl.handle.net/10261/304544, https://api.elsevier.com/content/abstract/scopus_id/85062971116
HANDLE: http://hdl.handle.net/10261/304544, https://api.elsevier.com/content/abstract/scopus_id/85062971116